synthesis of 2-(1-(-3-mercaptopropanoyl)-2-oxoindolin-3-ylidene)-n-phenyl/alkylhydrazinecarbothioamide derivatives as metallo-b- lactamase inhibitors and study of drug-enzyme interactions using molecular modeling